Featured Stories

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Revolade, Known in the U.S. as Promacta, Tied to Severe Hepatotoxicity Risks

The use of Revolade (eltrombopag) may cause severe hepatotoxicity and potentially deadly fatal liver injury, warns Canada’s health regulator, Health Canada, according to Healthy Canadians, Government of Canada. Revolade, which is a thrombopoietin receptor agonist, is manufactured and marketed by GlaxoSmithKline under the trade name Promacta in the United States. Promacta is marketed as Revolade in the European Union.

Cases of severe drug-induced Revolade liver injury that have led to hepatotoxicity and potentially fatal liver injury have been reported in patients during clinical trials and in the post-marketing period. Patients diagnosed with severe liver impairment are advised against taking Revolade, according to Healthy Canadians. Continue reading

Posted in Health Concerns, Pharmaceuticals |

New Claims Accepted for September 11 Victim Compensation Fund

September 11th Victim Compensation Fund (VCF) Special Master Rupa Bhattacharyya announced at the beginning of August that the VCF is again accepting new claims using a redesigned claim form with an improved online claims system. Individuals who do not have consistent Internet access will still be able to file a hard copy claim using the new form.

The staff for the 9/11 VCF has learned from the past five years how to reduce the number of frequently asked questions and combine the four previous versions into one, simplified form. The VCF staff also solicited input from various law firms that represent VCF claimants and incorporated their feedback into the redesigned system. Continue reading

Posted in Health Concerns, Legal News, Zadroga Act Claims |

Parasites in Community Pools Spark Outbreak in Arizona

A parasite that officials believe was in at least 20 community pools has sickened more than 100 people in Maricopa County, Arizona. The parasite is passed through stool and is commonly transmitted through contaminated drinking water or recreational water facilities that have infected fecal matter present.

Cryptosporidium, or “Crypto,”is a highly contagious parasite that is difficult to get rid of because chlorine is not always effective in killing it. According to the Mayo Clinic, alcohol-based hand sanitizer isn’t effective against Crypto, so washing hands with soap and water is found to be the best prevention. Continue reading

Posted in Health Concerns |

$70 Million Awarded in Risperdal Gynecomastia Lawsuit

An attempt was made by Johnson & Johnson (J&J) to overturn the largest award seen to date in a $70 million Risperdal gynecomastia verdict. The Pennsylvania judge presiding over the matter refused the request made by the manufacturer of J&J’s Janssen Pharmaceuticals division to reduce the award.

A young man began taking Risperdal in 2003 at the age of 5, to treat psychiatric problems. Risperdal was initially used to treat schizophrenia, but is also used for bipolar disorder and autism. It was not until 2013, that the man filed a lawsuit as he had developed abnormally large breasts, a condition called gynecomastia. Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals |

Skyrocketing Cost of EpiPen Worries Doctors and Patients

For children and adults who suffer from severe allergic reactions, the cost of EpiPens have gone through the roof in the past few years. This leaves those who are in need of the life-saving device scrambling in a market that offers minimal alternatives.

The drug’s manufacturer, Mylan, is being asked by members of Congress for more information on why the cost of a two-pen set is now listed at more than $600. When Mylan took over rights to EpiPen in 2007, a pair of syringes cost $93.88. Continue reading

Posted in Health Concerns, Pharmaceuticals |

Antibiotic Cipro Involved in Partial Settlement of a Class Action Lawsuit

Ciprofloxacin is a fluroquinolone antibiotic that fights different types of bacterial infections, such as urinary tract or gastrointestinal infections. It is also used to treat people who have been exposed to anthrax. Ciprofloxacin should only be used for infections that cannot be treated with a safer antibiotic as it has been known to cause some serious or disabling side effects.

Cipro has been the subject of a class action lawsuit where a partial settlement has been reached. The lawsuit claims that Bayer Corporation, Barr Laboratories, Inc., Hoechst Marion Roussel, Inc., Watson Pharmaceuticals, Inc., and The Rugby Group, Inc. violated antitrust and consumer protections laws by cooperating to not compete with one another. They also allegedly agreed to keep lower cost generic versions of Cipro off the market. The manufacturers deny this claim. Continue reading

Posted in Cipro, Class Action Lawsuits, Health Concerns, Pharmaceuticals |

Biomet Faces New Lawsuit over Metal-on-Metal Hip Implant

Biomet is facing a new lawsuit alleging that its metal-on-metal hip implant is to blame for a New York woman’s injuries. The plaintiff is a 61-year-old woman who was implanted with the Biomet M2a Magnum Hip Replacement System in her right hip six years ago. As the name implies, the implant is a metal-on-metal hip device where all contacting surfaces are made of metal. The suit alleges that the all-metal design caused the plaintiff to suffer injuries and ultimately implant failure, forcing her to undergo revision surgery to remove the implant.

The plaintiff alleges that she suffered severe and constant pain, swelling, tissue damage, synovial fluid buildup, lack of mobility and metal poisoning (metallosis). As a result of these complications, the lawsuit alleges, the plaintiff had to undergo revision surgery to remove the implant. The suit alleges that these injuries caused the plaintiff emotional distress and loss of enjoyment of her life. Continue reading

Posted in Legal News |

McDonald’s Recalls 29 Million Fitness Bands Due to Reports of Skin Irritation

Following reports of skin irritation and burns, McDonald’s is recalling 29 million “Step It!” fitness trackers included in some Happy Meals. According to a statement from the U.S. Consumer Product Safety Commission, McDonald’s received more than 70 reports of adverse events associated with the fitness bands, including seven reports of blisters.

Last week, the fast-food giant pulled the wristbands from stores in the United States and Canada. Company spokesperson Terri Hickey told USA Today said the wristbands are no longer being offered with Happy Meals. “We have taken this swift and voluntary step after receiving limited reports of potential skin irritations that may be associated with wearing the band,” she said in a statement. Continue reading

Posted in Defective Products, Health Concerns, Product Recalls | Tagged , , , , , |

Analysis Raises Questions about How Device Makers Label Patient Deaths

Medical device manufacturers are required to report any event that “reasonably suggests a device may have caused or contributed to a death or serious injury.” Madris Tomes, a former FDA consultant, conducted an analysis showing that 4,000 patient deaths were labeled as “injuries” or “malfunctions” between 2011 and 2015. She says these labels are important because they help determine which issues are priorities for public health analysts.

When a death gets categorized as an “injury” or “malfunction”, it delays reviews of that issue. “The way that the FDA reviews the [safety] reports is in order of importance by the classification that is checked on the form,” Tomes said, according to NBC. “So if it is an injury or malfunction, it could take them weeks to months to get to reading them.” Continue reading

Posted in Defective Medical Devices, Health Concerns | Tagged , , , , , , , |

Multi-vehicle Crash on Long Island Expressway Leaves 6 Dead, 5 Injured

A deadly crash over the weekend leaves six people dead and another five injured on Long Island. Authorities say a speeding SUV caused the crash when it came up fast on a work zone on the Long Island Expressway. The driver of the vehicle, a Subaru Outback, reportedly swerved to avoid the slowed traffic and collided with cars on the opposite side.

Several witnesses say the Subaru was speeding before it swerved and hurdled across the grassy median, according to Suffolk police Chief of Detectives Gerard Gigante. The car became airborne and slammed into two cars, a BMW and a Honda, heading west. The crash killed the 26-year-old driver of the Subaru, along with his 27-year-old sister and 10-year-old son. Continue reading

Posted in Accident, Legal News | Tagged , , , , , , , |

© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.